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Haematopoiesis represents one of the best studied 
models of adult stem cell development and diﬀ  erentiation 
[1,2]. Powerful techniques allow puriﬁ  cation and in vitro
as well as in vivo functional assays of small subsets of 
cells, from haematopoietic stem cells (HSCs) via a 
plethora of intermediate progenitors to fully mature cell 
types. Transcription factors (TFs) directly regulate gene 
expression and thus control cellular phenotypes. It is no 
surprise, therefore, that TFs have emerged as some of the 
most powerful regulators of both normal development 
and disease.
TFs play important roles during haematopoiesis, from 
stem cell maintenance to lineage commitment and 
diﬀ  erentiation. However, relatively little is known about 
the way in which regulatory information is encoded in 
the genome, and how individual TFs are integrated into 
wider regulatory networks. Based on the recent analysis 
of large-scale eﬀ  orts to reconstruct tissue-speciﬁ  c regu-
latory networks, it has been suggested that transcriptional 
regulatory networks are characterised by a high degree of 
connectivity between TFs and transcriptional cofactors. 
Extensive cross- and autoregulatory links therefore create 
densely connected regulatory circuits that control the 
large numbers of tissue-speciﬁ  c  eﬀ   ector proteins (en-
zymes, structural proteins) [3,4] (Figure 1). To under-
stand the functionality of large mammalian regulatory 
networks, it will therefore be important to identify 
downstream target genes of speciﬁ  c TFs as well as gain 
insight into combinatorial TF interactions. Th  is in turn 
will not only provide fundamental insights into normal 
development, but also advance our understanding of how 
deregulation of networks contributes to pathology.
Th  e cis-regulatory regions of a gene locus can be 
thought of as diﬀ  erent modules, each partaking in an 
important role, such as driving expression of the gene to 
a speciﬁ  c subset of cells or a speciﬁ  c tissue type. Th  e 
activity of each regulatory region is controlled by a 
distinct set of upstream regulators. Th   e individual regula-
tory regions within a given gene locus may have over-
lapping or very distinct upstream regulators, and it is the 
combined activity of all these regions that ultimately 
controls gene expression. Comprehensive identiﬁ  cation 
and characterisation of true functional cis-regulatory 
regions therefore represent an essential prerequisite to 
integrate important regulatory genes into wider trans-
crip  tional networks. Traditionally, DNaseI mapping was 
performed to identify regions of open/accessible chro-
matin. More recently, comparative genomic sequence 
analysis has been used to identify highly conserved 
sequences, which were taken to represent candidate 
regulatory elements based on the premise that sequence 
conservation indicated an important function [5-7]. Th  e 
most recent development has been that of whole genome 
re-sequencing, which when coupled with chromatin 
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of the chromatin status for a given histone modiﬁ  cation 
[8]. Th  ough more predictive than previous approaches, 
these techniques still require functional validation of 
candidate elements, which involves in vivo and in vitro
experiments to assess the true function of a given 
candidate regulatory region.
Several gene loci coding for TFs essential for haemato-
poiesis have been characterised using a combination of 
the above techniques. Collectively, these studies provided 
important insights into TF hierarchies and regulatory 
network core circuits [9-11]. Th   is review will speciﬁ  cally 
focus on three haematopoietic loci, encoding the key 
haematopoietic regulators Scl/Tal1, Lmo2 and Gﬁ  1.
Transcriptional regulation of Scl
Th   e basic helix-loop-helix TF Scl/Tal1 is a key regulator 
of haematopoiesis with additional important roles in the 
development of the vascular and central nervous systems 
[12-16]. Within the haematopoietic system, Scl is essen-
tial for the development of HSCs as well as further diﬀ  er-
entiation into the erythroid and megakaryocytic lineages 
[17].
Since correct spatio-temporal expression of Scl is 
crucial for the appropriate execution of its biological 
functions, much eﬀ   ort has been invested into under-
stand ing  how  Scl is regulated. Using a combination of 
long-range comparative sequence analysis and both in 
vitro and in vivo functional analysis, multiple cis-regula-
tory elements have been identiﬁ   ed in the murine Scl
locus, each of which directs expression to a subdomain of 
endogenous Scl expression when tested in transgenic 
mice (Figure 2). Scl has three promoters located in 
diﬀ  erent exons (exons 1a, 1b and exon 4), none of which 
displayed haematopoietic activity when tested in 
trans genic mice. A search for additional cis-regulatory 
elements led to the identiﬁ  cation of three haematopoietic 
enhancers  (-4, +19 and +40 kb). Th  e -4 Scl enhancer, 
characterized by the presence of ﬁ   ve Ets sites, drives 
expression to endothelium and fetal blood progenitors 
[18]. Th  e  +19  Scl enhancer was shown to drive expression 
of  Scl in HSCs, haematopoietic progenitors and 
endothelial cells [19-21] and critically depended on an 
Ets/Ets/GATA composite motif shown to be bound in 
vivo by Elf-1, Fli-1 and Gata2 [22]. Of note, the +19 
enhancer was ﬂ   anked by a nearby hypersensitive site 
(+18 Scl element), which did not function as an enhancer 
but contains a mammalian interspersed repeat that is 
essential for its ability to ‘boost’ activity of the +19 
element [23]. Th  e  +40  Scl enhancer drives expression to 
erythroid cells [24,25] as well as midbrain and is 
characterized by the presence of two Gata/E-box motifs. 
Mutation or deletion of a single one of these motifs leads 
to a loss of function of the enhancer [24,25].
Taken together, these studies have highlighted the 
presence of three haematopoietic enhancers within the 
murine Scl locus, with distinct yet overlapping regulatory 
codes that contribute to the overall correct spatio-
temporal expression of Scl. Interestingly, a recent study 
comparing the functionality of the mouse Scl enhancers 
with their corresponding chicken counterparts suggested 
that elements shared by mammals and lower vertebrates 
exhibit functional diﬀ  erences and binding site turnover 
between widely separated cis-regulatory modules [26]. 
Remarkably, however, the regulatory inputs and overall 
expression patterns remain the same across diﬀ  erent 
species. Th   is in turn suggested that signiﬁ  cant regulatory 
changes may be widespread, and not only apply to genes 
with altered expression patterns, but also to those where 
expression is highly conserved.
Transcriptional regulation of Lmo2
Th  e  Lim domain only 2 gene (Lmo2) encodes a trans  crip-
tional cofactor that is essential for haematopoiesis 
[27,28]. Th   e Lmo2 protein does not bind to DNA directly 
but rather participates in the formation of multipartite 
DNA-binding complexes with other TFs, such as Ldb1, 
Scl/Tal1, E2A and Gata1 or Gata2 [29-31]. Lmo2 is widely 
expressed across haematopoiesis with the exception of 
mature T-lymphoid cells where aberrant expression of 
Lmo2 results in T-cell leukaemias [32].
Lmo2 contains three promoters: the proximal pro  moter, 
which drives the majority of expression in endothelial 
cells [33]; the distal promoter, which is active in the fetal 
liver and speciﬁ   c T-cell acute lymphoblastic leukemia 
(T-ALL) cell lines [34]; and the intermediate promoter, 
which was detected in CD34+ cells and was implicated in 
mediating LMO2 expression in T-ALL patients where 
high levels of LMO2 were present in the absence of any 
Figure 1. Transcription factor networks control cellular 
phenotypes. Transcription factors (TFs) together with cofactors 
(Co-TF) form densely connected regulatory networks that defi  ne 
cellular phenotypes by regulating large numbers of eff  ector genes 
coding for cell-type-specifi  c structural proteins and enzymes.
TF2 TF1 Co-TF TF3
Densely Connected Transcription Factor Network
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none of the three promoters on their own displayed 
robust expression when tested in transgenic mice [33,36], 
which led to the identiﬁ  cation of eight enhancer elements 
dispersed over 100 kb that could recapitulate the 
expression of Lmo2 in normal haematopoiesis [36]. Of 
note, while individual elements augmented endothelial 
expression of the proximal promoter, robust haemato-
poietic expression was only observed when they were 
combined together (Figure 3). Th   is type of combinatorial 
collaboration between regulatory elements to obtain 
haematopoietic activity has been seen for other gene loci, 
such as Endoglin [37], suggesting a process of step-wise 
and modular activation of the locus during the 
development of blood and endothelial cells from their 
common precursor.
Transcriptional regulation of Gfi  1
Th  e  Growth factor independence 1 gene (Gﬁ  1) was origi-
nally identiﬁ  ed in a retroviral screen designed to identify 
regulatory pathways that could initiate interleukin-2 
independence in T cells [38]. Within the haematopoietic 
system Gﬁ  1 is expressed in HSCs [39], speciﬁ  c subsets of 
T cells [40], granulocytes, monocytes, and activated 
macro phages  [41].  Gﬁ  1-/- mice lack neutrophils [41,42] 
and  Gﬁ  1-/- HSCs are unable to maintain long-term 
haematopoiesis because elevated levels of proliferation 
lead to eventual exhaustion of the stem cell pool [39,43]. 
Outside the haematopoietic system, Gﬁ  1 is also speciﬁ  -
cally expressed in sensory epithelia, the lungs, neuronal 
precursors, the inner ear, intestinal epithelia and during 
mammary gland development [44-47].
A recent study used a combination of comparative 
genomics, locus-wide chromatin immunoprecipitation 
assays and functional validation within cell lines and 
transgenic animals to identify cis-regulatory regions 
within the Gﬁ  1 locus [48]. Four regulatory regions (-
3.4 kb min pro, -1.2 kb min pro, +5.8 kb enhancer and 
+35 kb enhancer) were shown to recapitulate endogenous 
expression patterns of Gﬁ  1 in the central nervous system, 
Figure 2. Scl cis-regulatory elements. The genomic locus of the murine Scl gene and adjacent genes are drawn schematically in the top panel 
(boxes represent exons and arrowheads indicate gene orientation). The middle diagram shows a Vista plot illustrating sequence conservation 
between the mouse and human Scl locus. Functional Scl cis-regulatory elements are highlighted in red. Bottom panels show whole mount LacZ 
staining of embryonic day 12.5 transgenic embryos and relevant histological sections for each individual Scl cis-regulatory element. The -4 Scl 
and +18/19 Scl enhancers target endothelium and haematopoietic progenitors; promoter 1a and the +23 Scl enhancer target ventral midbrain; 
promoter 1b targets hind brain and spinal cord, and the +40 Scl enhancer targets midbrain and erythroid cells [18-21,23-25].
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haematopoietic staining was observed. However, a recent 
genome-wide ChIP-Seq experiment [49] revealed binding 
of Scl/Tal1 to a region situated 35 kb upstream of the Gﬁ  1 
promoter within the last intron of its 5’ ﬂ  anking gene, 
Evi5. Th  is element was subsequently validated in trans-
genic assays, which demonstrated lacz staining at multi-
ple sites of haematopoietic stem/progenitor cell emer-
gence (vitelline vessels, fetal liver, and dorsal aorta). 
Moreover, the element was also shown to be bound by 
TFs known to be critical for haematopoiesis, including 
Scl/Tal1, Pu.1/Sfpi1, Runx1, Erg, Meis1, and Gata2, thus 
integrating Gﬁ  1 into the wider HSC regulatory network. 
Th   is study therefore supports the notion that important 
regulatory elements can be located at a signiﬁ  cant 
distance from the gene they control (Figure 4), and thus 
emphasize the need for careful interpretation of genome-
wide TF binding datasets [49,50].
Figure 3. Combinatorial interactions of distinct enhancers are critical to recapitulate the endogenous expression of Lmo2. (a) The Lmo2 
gene locus is drawn to scale. Exons are shown as black rectangles. Regulatory elements (-75/-70/-25/-12/pP/+1) are highlighted using shapes 
and distinct colours (-75 = orange diamond; -70 = green octagon; -25 = blue oval; dP = red rectangle; -12 = red triangle; +1 = purple triangle). 
(b) Transgenic animals were generated with many diff  erent combinations of the identifi  ed regulatory elements. The -75 enhancer and pP showed 
strong expression in endothelium, circulating erythrocytes and fetal liver. The -70 enhancer together with pP showed weak staining in endothelium 
and haematopoietic progenitor cells. The -25 or the -12 enhancer together with pP showed strong expression in endothelium and fetal liver. The +1 
enhancer with pP gave rise to lacZ staining in the tail, apical ridge of the limbs, fetal liver and strong endothelium. Only when these elements were 
coupled together was a staining pattern corresponding to endogenous expression of Lmo2 seen [36]. Strength of staining is indicated: +++, very 
strong; ++, intermediate; +, weak; -, not present.
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Page 4 of 8Figure 4. Combinatorial transcription factor binding identifi  ed the Gfi  1 -35 kb regulatory region. Raw ChIP-Seq read data from [50] were 
transformed into a density plot for each transcription factor and loaded into the UCSC genome browser as custom tracks above the UCSC tracks 
for gene structure and mammalian homology. A discreet binding event for all ten TFs (Scl/Tal1, Lyl1, Lmo2, Gata2, Runx1, Meis1, Pu.1, Fli1, Erg and 
Gfi  1b) can be seen in the last intron of the 5’ fl  anking gene, Evi5 (indicated by an asterisk). This region was subsequently shown to drive expression 
in early haematopoietic cells in transgenic mouse embryos [48].
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haematopoietic transcription factors
Th   e transcriptional control of several other TFs known to 
play important roles within haematopoiesis have also 
been investigated. Runx1 has been shown to be trans-
cribed from two promoter elements, both of which 
collaborate with the Runx1 +23 kb enhancer to drive 
expres  sion of Runx1 to sites of HSC emergence [51-53]. 
Moreover, the Runx1 +23 kb region was shown to be 
regulated by important haematopoietic TFs (Gata2, Fli1, 
Elf1, Pu.1, Scl, Lmo2, Ldb1 and Runx1 itself) [53,54]. Lyl1 
is known to contain a promoter region that can be 
divided into two separate promoter elements that are 
responsible for driving the expression of Lyl1 within 
endothelial, haematopoietic progenitor, and megakaryo-
cytic cells [55]. Th   ese promoter elements were shown to 
contain conserved Ets and Gata motifs that were bound 
in vivo by Fli1, Elf1, Erg, Pu.1, and Gata2. Multiple 
elements within the Gata2 locus have been identiﬁ  ed 
(-77 kb, -3.9 kb, -3 kb, -2.8 kb, -1.8 kb, +9.5 kb and 1s 
promoter) [56-58] with the -1.8 kb region being essential 
for maintaining Gata2 repression in terminally diﬀ  eren-
tiating cells [58]. Elf1 contains four promoter elements 
(-55 kb, -49 kb, -21 kb and proximal), which are used in a 
cell-type-speciﬁ  c manner in combination with a lineage-
speciﬁ  c -14 kb enhancer element [59]. Enhancer elements 
utilising the Ets/Ets/Gata regulatory code, originally 
deﬁ  ned in the Scl +19 enhancer, were also identiﬁ  ed in 
the Fli1, Gata2, Hhex/Prh and Smad6 gene loci [5,57]. 
Th  e picture emerging, therefore, is that transcriptional 
control of important haematopoietic TF loci is achieved 
through multiple regulatory elements but the number of 
upstream regulators may be relatively small. Th  e same 
binding motifs are repeatedly found, but it is the precise 
arrangement within a single element as well as the 
interactions between elements that ultimately control 
expression.
Conclusion
Recent analysis of gene regulatory networks controlling 
pluripotency in embryonic stem cells suggests that a 
ﬁ   nite number of major combinatorial interactions are 
critical in controlling cellular phenotypes [60,61]. Identi  ﬁ  -
cation and subsequent functional characterisation of 
speciﬁ  c regulatory elements provides a powerful route 
into deciphering these combinatorial regulatory inter-
actions. Whilst traditional methods of identifying regula-
tory elements should not be overlooked, it is essential to 
integrate new genome-wide methods to ensure that regu-
la  tory elements outside traditional gene loci boundaries 
are not overlooked. With the genome-wide mapping of 
TF binding events now eminently feasible, the impor-
tance of sequence conservation as a primary technique 
for identiﬁ  cation of regulatory elements will diminish. 
Nevertheless, genome-wide mapping of binding events is 
descriptive and therefore no substitute for conventional 
functional assays, which are therefore likely to remain an 
important component of any research programme aimed 
at elucidating transcriptional control mechanisms.
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